Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-27T20:53:52.671Z Has data issue: false hasContentIssue false

Chapter 15 - Pathophysiologyand animal models of frontotemporal dementia

from Section 4 - Pathology and pathophysiology

Published online by Cambridge University Press:  05 May 2016

By
Brian A. Warmus  and
Erik D. Roberson
Edited by
Bradford C. Dickerson
Bradford C. Dickerson
Affiliation:
Department of Neurology, Massachusetts General Hospital
Get access
Type
Chapter
Information
Hodges' Frontotemporal Dementia , pp. 197 - 210
Publisher: Cambridge University Press
Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

DeJesus-Hernandez, M, Mackenzie, IR, Boeve, BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245–56.CrossRefGoogle ScholarPubMed
Renton, AE, Majounie, E, Waite, A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257–68.Google Scholar
Rutherford, NJ, Heckman, MG, DeJesus-Hernandez, M, et al. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype. Neurobiol Aging 2012;33:2950.e5–7.CrossRefGoogle Scholar
Ciura, S, Lattante, S, Le Ber, I, et al. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann Neurol 2013;74(2):180–7.Google Scholar
Xi, Z, Zinman, L, Moreno, D, et al. Hypermethylation of the CpG island near the G4C2 repeat in ALS with a C9orf72 expansion. Am J Hum Genet 2013;92: 981–9.Google Scholar
Belzil, VV, Bauer, PO, Prudencio, M, et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol 2013;126:895–905.CrossRefGoogle ScholarPubMed
Haeusler, AR, Donnelly, CJ, Periz, G, et al. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 2014;507:195–200.CrossRefGoogle ScholarPubMed
Xu, Z, Poidevin, M, Li, X, et al. Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration. Proc Natl Acad Sci USA 2013;110:7778–83.Google Scholar
Gendron, TF, Bieniek, KF, Zhang, YJ, et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol 2013;126:829–44.Google Scholar
Ash, PE, Bieniek, KF, Gendron, TF, et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 2013;77:639–46.Google Scholar
Mori, K, Weng, SM, Arzberger, T, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 2013;339:1335–8.Google Scholar
Lagier-Tourenne, C, Baughn, M, Rigo, F, et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci USA 2013;110:E4530–9.Google Scholar
Lee, YB, Chen, HJ, Peres, JN, et al. Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic. Cell Rep 2013;5:1178–86.Google Scholar
van Swieten, J, Spillantini, MG. Hereditary frontotemporal dementia caused by tau gene mutations. Brain Pathol 2007;17:63–73.CrossRefGoogle ScholarPubMed
Hutton, M, Lendon, CL, Rizzu, P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702–5.Google Scholar
Poorkaj, P, Bird, TD, Wijsman, E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43:815–25.Google Scholar
Spillantini, MG, Murrell, JR, Goedert, M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998;95:7737–41.Google Scholar
Alzheimer Disease & Frontotemporal Dementia Mutation Database. Available from: http://www.molgen.ua.ac.be/FTDMutations.Google Scholar
Alonso Adel, C, Mederlyova, A, Novak, M, et al. Promotion of hyperphosphorylation by frontotemporal dementia tau mutations. J Biol Chem 2004;279:34873–81.Google Scholar
Liu, F, Gong, CX. Tau exon 10 alternative splicing and tauopathies. Mol Neurodegener 2008;3:8.Google Scholar
Goedert, M, Jakes, R. Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 1990;9:4225–30.Google Scholar
Brion, JP, Tremp, G, Octave, JN. Transgenic expression of the shortest human tau affects its compartmentalization and its phosphorylation as in the pretangle stage of Alzheimer's disease. Am J Pathol 1999;154:255–70.Google Scholar
Gotz, J, Probst, A, Spillantini, MG, et al. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J 1995;14:1304–13.Google Scholar
Probst, A, Gotz, J, Wiederhold, KH, et al. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol 2000;99:469–81.Google Scholar
Ishihara, T, Hong, M, Zhang, B, et al. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999;24:751–62.Google Scholar
Ishihara, T, Zhang, B, Higuchi, M, et al. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol 2001;158: 555–62.CrossRefGoogle ScholarPubMed
Higuchi, M, Ishihara, T, Zhang, B, et al. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 2002;35: 433–46.Google Scholar
Lewis, J, McGowan, E, Rockwood, J, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 2000;25:402–5.Google Scholar
Götz, J, Chen, F, Barmettler, R, et al. Tau filament formation in transgenic mice expressing P301L tau. J Biol Chem 2001;276:529–34.Google Scholar
SantaCruz, K, Lewis, J, Spires, T, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 2005;309:476–81.Google Scholar
Allen, B, Ingram, E, Takao, M, et al. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 2002;22:9340–51.Google Scholar
Spires, TL, Orne, JD, SantaCruz, K, et al. Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. Am J Pathol 2006;168:1598–607.Google Scholar
de Calignon, A, Fox, LM, Pitstick, R, et al. Caspase activation precedes and leads to tangles. Nature 2010;464:1201–4.Google Scholar
Andorfer, C, Acker, CM, Kress, Y, et al. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci 2005;25:5446–54.Google Scholar
Mocanu, MM, Nissen, A, Eckermann, K, et al. The potential for β-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous tau in inducible mouse models of tauopathy. J Neurosci 2008;28:737–48.Google Scholar
Kuchibhotla, KV, Wegmann, S, Kopeikina, KJ, et al. Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo. Proc Natl Acad Sci USA 2014;111:510–14.CrossRefGoogle ScholarPubMed
Rocher, AB, Crimins, JL, Amatrudo, JM, et al. Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs. Exp Neurol 2010;223:385–93.Google Scholar
Yoshiyama, Y, Higuchi, M, Zhang, B, et al. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007;53:337–51.Google Scholar
Sydow, A, Van der Jeugd, A, Zheng, F, et al. Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic tau mutant. J Neurosci 2011;31:2511–25.Google Scholar
Hoover, BR, Reed, MN, Su, J, et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 2010;68:1067–81.CrossRefGoogle ScholarPubMed
Yamada, K, Holth, JK, Liao, F, et al. Neuronal activity regulates extracellular tau in vivo. J Exp Med 2014;211:387–93.Google Scholar
Frost, B, Jacks, RL, Diamond, MI. Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 2009;284:12845–52.Google Scholar
Kfoury, N, Holmes, BB, Jiang, H, et al. Trans-cellular propagation of tau aggregation by fibrillar species. J Biol Chem 2012;287:19440–51.CrossRefGoogle ScholarPubMed
Guo, JL, Lee, VM. Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem 2011;286:15317–31.Google Scholar
Wu, JW, Herman, M, Liu, L, et al. Small misfolded tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J Biol Chem 2013;288:1856–70.Google Scholar
Clavaguera, F, Bolmont, T, Crowther, RA, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009;11:909–13.Google Scholar
Liu, L, Drouet, V, Wu, JW, et al. Trans-synaptic spread of tau pathology in vivo. PLoS One 2012;7:e31302.Google Scholar
de Calignon, A, Polydoro, M, Suárez-Calvet, M, et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012;73:685–97.Google Scholar
Seeley, WW, Crawford, RK, Zhou, J, et al. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009;62:42–52.Google Scholar
Seeley, WW. Anterior insula degeneration in frontotemporal dementia. Brain Struct Funct 2010;214:465–75.Google Scholar
Rabinovici, GD, Seeley, WW, Kim, EJ, et al. Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen 2007;22:474–88.Google Scholar
Zhou, J, Greicius, MD, Gennatas, ED, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease. Brain 2010;133:1352–67.Google Scholar
Zhou, J, Gennatas, ED, Kramer, JH, et al. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron 2012;73:1216–27.Google Scholar
Mackenzie, IR, Neumann, M, Baborie, A, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 2011;122:111–13.Google Scholar
Perry, DC, Lehmann, M, Yokoyama, JS, et al. Progranulin mutations as risk factors for Alzheimer disease. JAMA Neurol 2013;70:774–8.Google Scholar
Cenik, B, Sephton, CF, Kutluk Cenik, B, et al. Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration. J Biol Chem 2012;287:32298–306.Google Scholar
Van Damme, P, Van Hoecke, A, Lambrechts, D, et al. Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival. J Cell Biol 2008;181:37–41.Google Scholar
Gass, J, Lee, WC, Cook, C, et al. Progranulin regulates neuronal outgrowth independent of sortilin. Mol Neurodegener 2012;7:33.CrossRefGoogle ScholarPubMed
Bateman, A, Bennett, HP. The granulin gene family: from cancer to dementia. Bioessays 2009;31:1245–54.Google Scholar
Tang, W, Lu, Y, Tian, QY, et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 2011;332:478–84.Google Scholar
Chen, X, Chang, J, Deng, Q, et al. Progranulin does not bind tumor necrosis factor (TNF) receptors and is not a direct regulator of TNF-dependent signaling or bioactivity in immune or neuronal cells. J Neurosci 2013;33:9202–13.Google Scholar
Kao, AW, Eisenhut, RJ, Martens, LH, et al. A neurodegenerative disease mutation that accelerates the clearance of apoptotic cells. Proc Natl Acad Sci USA 2011;108:4441–6.Google Scholar
Yin, F, Banerjee, R, Thomas, B, et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 2010;207:117–28.Google Scholar
Ahmed, Z, Sheng, H, Xu, YF, et al. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging. Am J Pathol 2010;177:311–24.Google Scholar
Petkau, TL, Neal, SJ, Milnerwood, A, et al. Synaptic dysfunction in progranulin-deficient mice. Neurobiol Dis 2012;45:711–22.CrossRefGoogle ScholarPubMed
Filiano, AJ, Martens, LH, Young, AH, et al. Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice. J Neurosci 2013;33:5352–61.CrossRefGoogle ScholarPubMed
Finch, N, Carrasquillo, MM, Baker, M, et al. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 2011;76:467–74.Google Scholar
Chen-Plotkin, AS, Unger, TL, Gallagher, MD, et al. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. J Neurosci 2012;32:11213–27.Google Scholar
Kayasuga, Y, Chiba, S, Suzuki, M, et al. Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene. Behav Brain Res 2007;185:110–18.Google Scholar
Yin, F, Dumont, M, Banerjee, R, et al. Behavioral deficits and progressive neuropathology in progranulin-deficient mice: a mouse model of frontotemporal dementia. FASEB J 2010;24:4639–47.Google Scholar
Ghoshal, N, Dearborn, JT, Wozniak, DF, et al. Core features of frontotemporal dementia recapitulated in progranulin knockout mice. Neurobiol Dis 2012;45:395–408.Google Scholar
Wils, H, Kleinberger, G, Pereson, S, et al. Cellular ageing, increased mortality and FTLD-TDP-associated neuropathology in progranulin knockout mice. J Pathol 2012;228:67–76.Google Scholar
Ling, SC, Polymenidou, M, Cleveland, DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 2013;79:416–38.Google Scholar
Li, YR, King, OD, Shorter, J, et al. Stress granules as crucibles of ALS pathogenesis. J Cell Biol 2013;201:361–72.Google Scholar
Lattante, S, Rouleau, GA, Kabashi, E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum Mutat 2013;34:812–26.Google Scholar
Cushman, M, Johnson, BS, King, OD, et al. Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 2010;123:1191–201.Google Scholar
King, OD, Gitler, AD, Shorter, J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res 2012;1462:61–80.Google Scholar
Wu, LS, Cheng, WC, Hou, SC, et al. TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis 2010;48:56–62.Google Scholar
Sephton, CF, Good, SK, Atkin, S, et al. TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem 2010;285:6826–34.Google Scholar
Kraemer, BC, Schuck, T, Wheeler, JM, et al. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol 2010;119:409–19.Google Scholar
Chiang, P-M, Ling, J, Jeong, YH, et al. Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci USA 2010;107:16320–4.Google Scholar
Iguchi, Y, Katsuno, M, Niwa, J, et al. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain 2013;136:1371–82.Google Scholar
Wu, LS, Cheng, WC, Shen, CK. Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J Biol Chem 2012;287:27335–44.Google Scholar
Hicks, GG, Singh, N, Nashabi, A, et al. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat Genet 2000;24:175–9.Google Scholar
Tsao, W, Jeong, YH, Lin, S, et al. Rodent models of TDP-43: recent advances. Brain Res 2012;1462:26–39.Google Scholar
Roberson, ED. Mouse models of frontotemporal dementia. Ann Neurol 2012;72:837–49.Google Scholar
Ayala, YM, De Conti, L, Avendano-Vazquez, SE, et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 2011;30:277–88.Google Scholar
Verbeeck, C, Deng, Q, DeJesus-Hernandez, M, et al. Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Mol Neurodegener 2012;7:53.Google Scholar
Mitchell, JC, McGoldrick, P, Vance, C, et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol 2013;125:273–88.CrossRefGoogle Scholar
Qiu, H, Lee, S, Shang, Y, et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest 2014;124:981–99.Google Scholar
Watts, GD, Wymer, J, Kovach, MJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004;36:377–81.Google Scholar
van der Zee, J, Pirici, D, Van Langenhove, T, et al. Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His. Neurology 2009;73:626–32.Google Scholar
Kim, EJ, Park, YE, Kim, DS, et al. Inclusion body myopathy with Paget disease of bone and frontotemporal dementia linked to VCP p.Arg155Cys in a Korean family. Arch Neurol 2011;68:787–96.Google Scholar
Forman, MS, Mackenzie, IR, Cairns, NJ, et al. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol 2006;65:571–81.Google Scholar
Müller, JM, Deinhardt, K, Rosewell, I, et al. Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality. Biochem Biophys Res Commun 2007;354:459–65.Google Scholar
Badadani, M, Nalbandian, A, Watts, GD, et al. VCP associated inclusion body myopathy and Paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS One 2010;5:e13183.Google Scholar
Custer, SK, Neumann, M, Lu, H, et al. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum Mol Genet 2010;19:1741–55.Google Scholar
Rodriguez-Ortiz, CJ, Hoshino, H, Cheng, D, et al. Neuronal-specific overexpression of a mutant valosin-containing protein associated with IBMPFD promotes aberrant ubiquitin and TDP-43 accumulation and cognitive dysfunction in transgenic mice. Am J Pathol 2013;183:504–15.Google Scholar
Yin, HZ, Nalbandian, A, Hsu, CI, et al. Slow development of ALS-like spinal cord pathology in mutant valosin-containing protein gene knock-in mice. Cell Death Dis 2012;3:e374.Google Scholar
Llewellyn, KJ, Nalbandian, A, Jung, KM, et al. Lipid-enriched diet rescues lethality and slows down progression in a murine model of VCP-associated disease. Hum Mol Genet 2014;23:1333–44.Google Scholar
Gydesen, S, Brown, JM, Brun, A, et al. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 2002;59:1585–94.Google Scholar
Holm, IE, Englund, E, Mackenzie, IR, et al. A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J Neuropathol Exp Neurol 2007;66:884–91.Google Scholar
Holm, IE, Isaacs, AM, Mackenzie, IR. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Acta Neuropathol 2009;118:719–20.Google Scholar
Cox, LE, Ferraiuolo, L, Goodall, EF, et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One 2010;5:e9872.Google Scholar
Skibinski, G, Parkinson, NJ, Brown, JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005;37:806–8.Google Scholar
Lee, JA, Beigneux, A, Ahmad, ST, et al. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr Biol 2007;17:1561–7.Google Scholar
Ghazi-Noori, S, Froud, KE, Mizielinska, S, et al. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Brain 2012;135:819–32.Google Scholar
Thomas, M, Alegre-Abarrategui, J, Wade-Martins, R. RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum. Brain 2013;136:1345–60.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×